PFM Health Sciences’s Spectranetics Corp SPNC Stock Holding History

PFM Health Sciences’s Portfolio SPNC Stock Details SPNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-675,383	Closed	-$25.9M	–	112
2017 Q2	$25.9M	Sell	675,383 -775,647	-53%	-$22.4M	0.7%	49
2017 Q1	$42.3M	Buy	1,451,030 +85,085	+6%	+$2.27M	1.06%	39
2016 Q4	$33.5M	Buy	1,365,945 +1,197,900	+713%	+$28.2M	0.94%	38
2016 Q3	$4.22M	Sell	168,045 -89,974	-35%	-$2.1M	0.12%	81
2016 Q2	$4.83M	Sell	258,019 -35,561	-12%	-$626K	0.15%	72
2016 Q1	$4.26M	Buy	+293,580	New	+$4.06M	0.13%	78

PFM Health Sciences's SPNC Position: Q3 2017 in Review

PFM Health Sciences sold out of Spectranetics Corp (SPNC) in Q3 2017, closing a stake of 675,383 shares — an estimated $25.9M sold.

PFM Health Sciences first reported a position in SPNC in Q1 2016 and held it in 6 quarters. The position peaked at $42.3M in Q1 2017. 0 funds tracked by Wall St. Rank hold SPNC as of Q3 2017.

PFM Health Sciences reported no remaining Spectranetics Corp position as of Q3 2017 after selling out during the quarter.
PFM Health Sciences sold 675,383 Spectranetics Corp shares in Q3 2017, an estimated $25.9M.
PFM Health Sciences first reported a position in Spectranetics Corp in Q1 2016 and held it in 6 quarters.
PFM Health Sciences's Spectranetics Corp position peaked at $42.3M in Q1 2017.
0 funds tracked by Wall St. Rank held Spectranetics Corp as of Q3 2017.

Based on PFM Health Sciences's 13F filing for Q3 2017, filed 14 Nov 2017.